US Archives - Page 60 of 100 - European Medical Journal

Functional Outcomes After Respiratory Failure Explored

Respiratory failure impacts millions annually in the U.S., leaving many survivors with lasting physical, cognitive, and quality-of-life impairments.

Omega-3 Diet Reduces Prostate Cancer Progression

A recent Phase II clinical trial has revealed promising results for men with low-grade prostate cancer on active surveillance (AS).

VISIBLE Study Drives Diversity in Psoriasis Research

In an effort to improve psoriasis research, the VISIBLE clinical trial has made significant strides in diversity, enrolling participants with skin of color (SoC) at an accelerated rate.

Dynamic Model Improves Migrant Tuberculosis Detection

Tuberculosis (TB) remains a persistent health concern among migrants to low-TB-incidence countries, including Canada.

Estrogen-Progesterone Therapy Linked to Autoimmune Risks

A recent study exploring the impact of estrogen and progesterone analog supplementation on autoimmune conditions reveals a concerning association with several diseases.

AI Model Predicts Outcomes for Patients with Breast Cancer on CDK4/6 Inhibitors: SABCS 2024

A new AI-powered model predicts outcomes for breast cancer patients on CDK4/6 inhibitors, offering precise insights into treatment response and enabling personalized care.

Predictors of Psoriatic Arthritis in Juvenile Arthritis

Insights into predicting psoriatic arthritis (PsA) in juvenile idiopathic arthritis (JIA) patients, 18 years after their initial diagnosis, were shared in a recent study.

Burn Patients Face Pneumonia Risk Surge

A newly published study highlights a critical connection between inhalation injury severity and the risk of developing nosocomial pneumonia (NP) in burn patients.

Can Exercise and Brain Stimulation Help Patients With ALS?

A recent meta-analysis sheds light on nonpharmacologic treatments for amyotrophic lateral sclerosis (ALS), specifically active exercise and noninvasive brain stimulation (NIBS).

Genomic Testing Guides Chemotherapy Choices in Breast Cancer: SABCS 2024

In this study, patients with a recurrence scores greater than 31 exhibited significant improvements in survival outcomes when treated with taxane and anthracycline-based chemotherapy.